0.00Open0.20Pre Close0 Volume86 Open Interest17.50Strike Price0.00Turnover260.10%IV158.77%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier21DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.1204Delta0.0466Gamma34.20Leverage Ratio-0.0200Theta0.0004Rho4.12Eff Leverage0.0033Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet